SCHEMBL30753265

SCHEMBL30753265

O=Cc1cc(O)cc(Br)c1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.46
▸ ERN1 O75460 4/20 0.43
▸ ALDH5A1 P51649 2/20 0.42
▸ ABAT P80404 2/20 0.42
▸ LCK P06239 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.38
▸ PTGS2 P35354 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ MAOA P21397 2/20 0.36
▸ MAOB P27338 2/20 0.36
▸ TDP1 Q9NUW8 2/20 0.35
▸ AOX1 Q06278 1/20 0.35
▸ TRIM24 O15164 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ TRIM33 Q9UPN9 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ XDH P47989 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL668005 1.00 ALDH1A1 (0.46) ALDH1A1ERN1ALDH5A1ABATLCK
SCHEMBL4575600 0.82 ALDH5A1 (0.52) ALDH1A1ALDH5A1ABATLCKKDM4E
SCHEMBL9261197 0.82 LCK (0.58) ALDH1A1ALDH5A1ABATLCKKDM4E
SCHEMBL708554 0.82 ALDH1A1 (0.56) ALDH1A1ERN1ALDH5A1ABATKDM4E
SCHEMBL646947 0.82 ALDH1A1 (0.56) ALDH1A1ERN1ALDH5A1ABATKDM4E
SCHEMBL37131 0.82 LCK (0.58) ALDH1A1ALDH5A1ABATLCKKDM4E
Potassium SCHEMBL31540630 0.79 LCK (0.55) ALDH1A1ALDH5A1ABATLCKKDM4E
Phloroglucinol SCHEMBL28580013 0.76 ALDH5A1 (0.52) ALDH1A1ALDH5A1ABATLCKKDM4E
SCHEMBL16955787 0.76 LCK (0.40) ALDH1A1LCKKDM4EPTGS2RAB9A
SCHEMBL25180638 0.73 KDM4E (0.53) ALDH1A1LCKKDM4EPTGS2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4565562-A1 PYRROLIDINE-2-CARBOXAMIDE DERIVATIVES AS PROSTAGLANDIN E2 RECEPTOR 4 (EP4) AGONISTS FOR THE TREATMENT OF GASTROINTESTINAL AND PULMONARY DISEASES Nxera Pharma UK Limited (GB) 2025-06-11 — — EP disclosed
WO-2024028603-A1 PYRROLIDINE-2-CARBOXAMIDE DERIVATIVES AS PROSTAGLANDIN E2 RECEPTOR 4 (EP4) AGONISTS FOR THE TREATMENT OF GASTROINTESTINAL AND PULMONARY DISEASES HEPTARES THERAPEUTICS LIMITED (GB) 2024-02-08 — — WO disclosed
Send feedback